Vancouver, British Columbia / TheNewswire / February 2, 2015 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF), developer of the patent-pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that the development of its marijuana breathalyzer prototype is proceeding as planned with the mechanical design, circuit board layouts, firmware, and printed circuit board designs all nearing completion.

Cannabix is developing a feature rich, durable, hand-held marijuana breathalyzer device for law enforcement and the workplace.

"We expect our prototype to be complete in the coming weeks and we'll be sharing news about testing," said Kal Malhi, President of Cannabix Technologies Inc. "Our team is working hard to deliver a prototype for trial testing as quickly as possible."

The Company also reports that Dr. Raj Attariwala, MD, PhD, will be joining the Cannabix Board of Directors, subject to ratification at the AGM and special meeting to be held in February, 2015.

Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He holds a doctorate in Biomedical Engineering from Northwestern University. Dr. Attariwala is Cannabix's lead product development engineer and has utilized his educational training and background in biomedical engineering to formulate product design and patent applications for Cannabix breathalyzer products.

For more information and to sign up for email updates please visit cannabixtechnologies.com

About Cannabix Technologies Inc.

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana. Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions. Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous. The device is currently in prototype development and the Company is rapidly developing this technology.

We seek Safe Harbor.

On behalf of the Board of Directors

"Rav Mlait"

CEO

Cannabix Technologies Inc.